Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Does Cinnamon Lower ALT Levels for Liver Health?

A user asks if cinnamon can lower ALT levels to support liver health. The assistant explains that research suggests cinnamon may reduce ALT, especially in NAFLD patients, due to its antioxidant and anti-inflammatory effects, while noting cautions about coumarin in Cassia cinnamon.


  • I've heard cinnamon might help with liver health—does it actually lower ALT levels?

  • That's a very interesting question! While Pillser's database doesn't have specific studies on cinnamon and ALT levels, here's what the broader scientific literature suggests.

    Cinnamon and ALT Levels

    Yes, there is evidence that cinnamon supplementation may help lower ALT (alanine aminotransferase) levels, particularly in people with non-alcoholic fatty liver disease (NAFLD).

    What the research shows:

    • Several meta-analyses of randomized controlled trials have found that cinnamon supplementation can lead to significant reductions in ALT levels.
    • The effect appears most pronounced in individuals with higher baseline ALT levels (i.e., those with existing liver issues) rather than in healthy individuals with normal enzyme levels.
    • Cinnamon's active compounds, particularly cinnamaldehyde and various polyphenols, are thought to exert antioxidant and anti-inflammatory effects that help protect liver cells from damage.

    How it might work:

    • Antioxidant activity — Cinnamon reduces oxidative stress in the liver, a key driver of liver cell injury.
    • Anti-inflammatory effects — It suppresses pro-inflammatory cytokines that contribute to liver inflammation.
    • Improved insulin sensitivity — By helping regulate blood sugar, cinnamon may reduce metabolic stress on the liver, which is especially relevant for NAFLD.

    Typical doses used in studies:

    Doses ranging from 500 mg to 3 grams per day of cinnamon powder or extract (often Cassia cinnamon) have been used in clinical trials lasting 8–16 weeks.

    Important caveats:

    • Cassia vs. Ceylon cinnamon — Most studies use Cassia cinnamon, which contains coumarin, a compound that can be toxic to the liver in high doses. Long-term or high-dose use of Cassia cinnamon is not recommended. Ceylon cinnamon ("true cinnamon") has much lower coumarin content and is safer for regular use.
    • The effect size is modest — While statistically significant, the reductions in ALT are generally small to moderate. Cinnamon should be viewed as a complementary approach, not a replacement for medical treatment.

    Would you like me to search for specific supplement products containing cinnamon that might be relevant?

Browse Related Questions

Back to top